Metabolic Dysfunction-Associated Fatty Liver Disease on Distinct Microbial Communities at the Bacterial Phylum Level
出版年份 2023 全文链接
标题
Metabolic Dysfunction-Associated Fatty Liver Disease on Distinct Microbial Communities at the Bacterial Phylum Level
作者
关键词
-
出版物
DIGESTIVE DISEASES
Volume -, Issue -, Pages 1-9
出版商
S. Karger AG
发表日期
2023-11-01
DOI
10.1159/000534284
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome
- (2022) Xiao Yu et al. Frontiers in Cellular and Infection Microbiology
- Hepatic encephalopathy
- (2022) Dieter Häussinger et al. Nature Reviews Disease Primers
- Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates Nonalcoholic Steatohepatitis through Innate and Adaptive Signaling
- (2021) Fanta Barrow et al. HEPATOLOGY
- Role and Mechanism of Gut Microbiota in Human Disease
- (2021) Yinwei Chen et al. Frontiers in Cellular and Infection Microbiology
- Mining Gut Microbiota From Bariatric Surgery for MAFLD
- (2021) Wei-Kai Wu et al. Frontiers in Endocrinology
- Dysbiosis and liver diseases (Review)
- (2021) Hiroki Nishikawa et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
- (2021) Hitoshi Yoshiji et al. JOURNAL OF GASTROENTEROLOGY
- Gut barrier and microbiota in cirrhosis
- (2021) Cyriac Abby Philips et al. Journal of Clinical and Experimental Hepatology
- Prevalence of Blastocystis and its association with Firmicutes/Bacteroidetes ratio in clinically healthy and metabolically ill subjects
- (2021) Claudia Muñoz Yañez et al. BMC MICROBIOLOGY
- Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid
- (2021) Weijia Han et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The microbial metabolome in metabolic‐associated fatty liver disease
- (2021) Mengci Li et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Association of Neonatal Jaundice with Gut Dysbiosis Characterized by Decreased Bifidobacteriales
- (2021) Shohei Akagawa et al. Metabolites
- Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?
- (2020) Judith Aron-Wisnewsky et al. GASTROENTEROLOGY
- Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
- (2020) Jasmohan S. Bajaj et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
- (2020) Fabien Magne et al. Nutrients
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- The Role of the Gut Microbiome in Liver Cirrhosis Treatment
- (2020) Na Young Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical utility of the MAFLD definition
- (2020) Kenneth I. Zheng et al. JOURNAL OF HEPATOLOGY
- MR elastography: Principles, guidelines, and terminology
- (2020) Armando Manduca et al. MAGNETIC RESONANCE IN MEDICINE
- Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature
- (2019) Ivana Milosevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
- (2019) Juliette Mouries et al. JOURNAL OF HEPATOLOGY
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients with Cirrhosis
- (2018) Jasmohan S. Bajaj et al. Clinical Gastroenterology and Hepatology
- The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis
- (2018) Feng-Bin Lu et al. Expert Review of Gastroenterology & Hepatology
- The Microbiome in Cirrhosis and Its Complications
- (2018) Chathur Acharya et al. Clinical Gastroenterology and Hepatology
- Association of serum bilirubin in newborns affected by jaundice with gut microbiota dysbiosis
- (2018) Shaoming Zhou et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
- (2018) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
- (2017) Junli Ma et al. Nutrients
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
- (2016) Kento Imajo et al. GASTROENTEROLOGY
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
- (2013) Genta Kakiyama et al. JOURNAL OF HEPATOLOGY
- Pathological bacterial translocation in liver cirrhosis
- (2013) Reiner Wiest et al. JOURNAL OF HEPATOLOGY
- The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
- (2009) D Mariat et al. BMC MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started